The U.S. House Committee on Oversight and Accountability held a hearing last month with the CEOs of the nation’s three largest pharmacy benefit managers: CVS Caremark, Express Scripts, and OptumRx.
The hearing coincided with a new report from the committee on the outsized role these prescription-drug middlemen play in determining what people pay for their medicines.
Unsurprisingly, the CEO confab revealed little that lawmakers didn’t already know.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Legislation Urgently Needed to Rein In Pharmacy Benefit Mgrs.
Sally C. Pipes
The U.S. House Committee on Oversight and Accountability held a hearing last month with the CEOs of the nation’s three largest pharmacy benefit managers: CVS Caremark, Express Scripts, and OptumRx.
The hearing coincided with a new report from the committee on the outsized role these prescription-drug middlemen play in determining what people pay for their medicines.
Unsurprisingly, the CEO confab revealed little that lawmakers didn’t already know.
Click to read the full article in Newsmax.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.